Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy
Node-positive Breast Cancer
About this trial
This is an interventional treatment trial for Node-positive Breast Cancer
Eligibility Criteria
Inclusion Criteria: females with invasive breast cancer with axillary metastasis, staging of n1: n2 complete axillary response to neoadjuvant therapy by clinical examination and imaging Exclusion Criteria: 1. breast cancer patients who are not candidate for neoadjuvant chemotherapy 2. breast cancer patients with positive axillary node post neoadjuvant chemotherapy 3. breast cancer patients with distant metastasis 4. patients with axillary lymph node metastasis from another primary tumour [not breast cancer]
Sites / Locations
Arms of the Study
Arm 1
Experimental
Breast cancer patients with positive axillary nodes
Female with invasive breast cancer with axillary metastasis , who recieve neo adjuvant therapy with complete axillary response